300267 尔康制药
已收盘 04-17 15:00:00
资讯
新帖
简况
尔康制药：公司战略目标上聚力于夯实发展基础
证券之星 · 04-08
尔康制药：公司战略目标上聚力于夯实发展基础
尔康制药：公司践行医药+新能源材料双主业驱动发展战略
证券之星 · 04-08
尔康制药：公司践行医药+新能源材料双主业驱动发展战略
尔康制药(300267.SZ)控股股东帅放文拟减持不超2.04%股份
智通财经 · 03-31
尔康制药(300267.SZ)控股股东帅放文拟减持不超2.04%股份
尔康制药：公司尼日利亚工厂原料以锂辉石为主
证券之星 · 03-13
尔康制药：公司尼日利亚工厂原料以锂辉石为主
尔康制药（300267）披露审计机构变更项目质量复核人公告，3月2日股价下跌3.86%
证券之星 · 03-02
尔康制药（300267）披露审计机构变更项目质量复核人公告，3月2日股价下跌3.86%
异动快报：尔康制药（300267）2月26日9点36分触及涨停板
证券之星 · 02-26
异动快报：尔康制药（300267）2月26日9点36分触及涨停板
尔康制药（300267）披露控股股东减持计划期限届满未减持股份公告，1月28日股价下跌2.5%
证券之星 · 01-28
尔康制药（300267）披露控股股东减持计划期限届满未减持股份公告，1月28日股价下跌2.5%
尔康制药：公司业务未涉及脑机接口领域
证券之星 · 01-13
尔康制药：公司业务未涉及脑机接口领域
尔康制药：公司目前在海外主要是锂矿勘探、开采和选矿业务
证券之星 · 01-13
尔康制药：公司目前在海外主要是锂矿勘探、开采和选矿业务
异动快报：尔康制药（300267）1月13日10点30分触及涨停板
证券之星 · 01-13
异动快报：尔康制药（300267）1月13日10点30分触及涨停板
尔康制药（300267）披露2025年第二次临时股东会决议公告，12月16日股价下跌2.58%
证券之星 · 2025-12-16
尔康制药（300267）披露2025年第二次临时股东会决议公告，12月16日股价下跌2.58%
尔康制药（300267）披露完成工商变更登记公告，12月09日股价下跌4.45%
证券之星 · 2025-12-09
尔康制药（300267）披露完成工商变更登记公告，12月09日股价下跌4.45%
尔康制药：有缓解流感症状药品
证券之星 · 2025-12-05
尔康制药：有缓解流感症状药品
尔康制药：尼日利亚孙公司锂矿已投产
证券之星 · 2025-12-05
尔康制药：尼日利亚孙公司锂矿已投产
尔康制药（300267）披露召开2025年第二次临时股东会通知，11月27日股价下跌1.73%
证券之星 · 2025-11-27
尔康制药（300267）披露召开2025年第二次临时股东会通知，11月27日股价下跌1.73%
尔康制药（300267）披露选举第六届董事会成员，11月17日股价下跌0.51%
证券之星 · 2025-11-17
尔康制药（300267）披露选举第六届董事会成员，11月17日股价下跌0.51%
尔康制药（300267）披露选举第六届董事会职工代表董事，11月12日股价上涨0.78%
证券之星 · 2025-11-12
尔康制药（300267）披露选举第六届董事会职工代表董事，11月12日股价上涨0.78%
尔康制药：暂无直接针对减肥领域的专项产品及业务布局
证券之星 · 2025-11-05
尔康制药：暂无直接针对减肥领域的专项产品及业务布局
尔康制药（300267）2025年三季报简析：营收净利润同比双双增长
证券之星 · 2025-10-31
尔康制药（300267）2025年三季报简析：营收净利润同比双双增长
尔康制药新提交1件商标注册申请
证券之星 · 2025-03-06
尔康制药新提交1件商标注册申请
公司概况
公司名称：
湖南尔康制药股份有限公司
所属行业：
医药制造业
上市日期：
2011-09-27
主营业务：
湖南尔康制药股份有限公司的主营业务是辅料、原料药、成品药、新能源材料的生产和销售。公司的主要产品是药用辅料、成品药、原料药。
发行价格：
17.97
{"stockData":{"symbol":"300267","market":"SZ","secType":"STK","nameCN":"尔康制药","latestPrice":4.02,"timestamp":1776409413000,"preClose":4.09,"halted":0,"volume":79225017,"delay":0,"changeRate":-0.0171,"floatShares":1422000000,"shares":2063000000,"eps":-0.1495,"marketStatus":"已收盘","change":-0.07,"latestTime":"04-17 15:00:00","open":4.08,"high":4.17,"low":3.99,"amount":321000000,"amplitude":0.044,"askPrice":4.02,"askSize":3543,"bidPrice":4.01,"bidSize":7985,"shortable":0,"etf":0,"ttmEps":-0.1495,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776648600000},"marketStatusCode":5,"adr":0,"adjPreClose":4.09,"symbolType":"stock","openAndCloseTimeList":[[1776389400000,1776396600000],[1776402000000,1776409200000]],"highLimit":4.5,"lowLimit":3.68,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":2062604870,"isCdr":false,"pbRate":1.89,"roa":"--","roe":"0.89%","epsLYR":-0.181,"committee":0.366242,"marketValue":8292000000,"turnoverRate":0.0557,"status":1,"floatMarketCap":5718000000},"requestUrl":"/m/hq/s/300267/wiki","defaultTab":"wiki","newsList":[{"id":"2625941483","title":"尔康制药：公司战略目标上聚力于夯实发展基础","url":"https://stock-news.laohu8.com/highlight/detail?id=2625941483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625941483?lang=zh_cn&edition=full","pubTime":"2026-04-08 20:52","pubTimestamp":1775652772,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药04月08日在投资者关系平台上答复投资者关心的问题。公司在股权管理上会综合宏观环境、企业发展、经营状况、团队建设等因素进行考量，公司战略目标上聚力于夯实发展基础，提升经营业绩，积极传递和提升公司价值，维护公司和广大投资者的合法权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800036500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267","BK0239","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625457941","title":"尔康制药：公司践行医药+新能源材料双主业驱动发展战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2625457941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625457941?lang=zh_cn&edition=full","pubTime":"2026-04-08 20:52","pubTimestamp":1775652772,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药04月08日在投资者关系平台上答复投资者关心的问题。公司践行医药+新能源材料双主业驱动发展战略，顺应形势和环境变化，积极转型发展，打造新的利润增长点，努力夯实公司价值创造基础。公司市值管理工作以规范运作为前提、提升经营业绩为核心手段，同时通过多种渠道加强投资者关系管理。重大事项公司将依法依规履行信息披露义务。感谢您对公司的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800036501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","09939","BK1161","300267","BK0239","BK1574","BK1515","159875","160640","399941","000941.SH","BK0028","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623758811","title":"尔康制药(300267.SZ)控股股东帅放文拟减持不超2.04%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2623758811","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623758811?lang=zh_cn&edition=full","pubTime":"2026-03-31 18:36","pubTimestamp":1774953379,"startTime":"0","endTime":"0","summary":"智通财经APP讯，尔康制药(300267.SZ)公告，公司控股股东帅放文先生计划在2026年4月23日至2026年7月22日以集中竞价或大宗交易方式合计减持公司股份不超过4200万股，即不超过公司总股本的2.04%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300267","BK0077","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619197781","title":"尔康制药：公司尼日利亚工厂原料以锂辉石为主","url":"https://stock-news.laohu8.com/highlight/detail?id=2619197781","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619197781?lang=zh_cn&edition=full","pubTime":"2026-03-13 20:52","pubTimestamp":1773406330,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药(300267)03月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董事长您好，贵公司在尼日利亚锂矿中还有别的贵金属吗。尔康制药回复：尊敬的投资者，您好！公司尼日利亚工厂原料以锂辉石为主。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300038454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267","BK0028","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616353876","title":"尔康制药（300267）披露审计机构变更项目质量复核人公告，3月2日股价下跌3.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616353876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616353876?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:17","pubTimestamp":1772461035,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，尔康制药报收于4.23元，较前一交易日下跌3.86%，最新总市值为87.25亿元。尔康制药于近日披露《关于审计机构变更项目质量复核人的公告》。尹志彬先生自2007年起从事上市公司审计业务，2009年成为注册会计师，近三年签署及复核多家上市公司审计报告，未因执业行为受到处罚，符合独立性要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200039670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267","BK0239","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614061539","title":"异动快报：尔康制药（300267）2月26日9点36分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2614061539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614061539?lang=zh_cn&edition=full","pubTime":"2026-02-26 09:40","pubTimestamp":1772070045,"startTime":"0","endTime":"0","summary":"证券之星2月26日盘中消息，9点36分尔康制药触及涨停板。其所属行业化学制药目前下跌。领涨股为尔康制药。该股为中药，化学原料药，合成生物概念热股，当日中药概念上涨0.3%，化学原料药概念上涨0.25%，合成生物概念上涨0.19%。2月25日的资金流向数据方面，主力资金净流出2726.77万元，占总成交额12.24%，游资资金净流入911.52万元，占总成交额4.09%，散户资金净流入1815.26万元，占总成交额8.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600006754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267","BK0077","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606712739","title":"尔康制药（300267）披露控股股东减持计划期限届满未减持股份公告，1月28日股价下跌2.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606712739","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606712739?lang=zh_cn&edition=full","pubTime":"2026-01-28 22:13","pubTimestamp":1769609599,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，尔康制药报收于4.29元，较前一交易日下跌2.5%，最新总市值为88.49亿元。公告显示，公司于2025年9月29日披露控股股东帅放文先生拟自2025年10月29日至2026年1月28日通过集中竞价或大宗交易方式减持公司股份不超过42,000,000股，即不超过公司总股本的2.04%。截至2026年1月28日，减持计划期限届满，帅放文先生未减持公司股份。本次减持计划实施期间未发生股份变动，不影响公司控制权及治理结构。相关减持行为符合法律法规及监管规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800042631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300267","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603681900","title":"尔康制药：公司业务未涉及脑机接口领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2603681900","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603681900?lang=zh_cn&edition=full","pubTime":"2026-01-13 20:52","pubTimestamp":1768308770,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药(300267)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司未来有准备脑机接口等业务吗？尔康制药回复：尊敬的投资者，您好！公司业务未涉及脑机接口领域，公司将积极关注行业前沿技术的发展。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300039838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0239","300267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603681153","title":"尔康制药：公司目前在海外主要是锂矿勘探、开采和选矿业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2603681153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603681153?lang=zh_cn&edition=full","pubTime":"2026-01-13 20:52","pubTimestamp":1768308769,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药(300267)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董事长董秘你们好。钠离子电池代替锂离子电池是大势所趋。公司持有海外锂矿是否有投资风险？尔康制药回复：尊敬的投资者，您好！公司目前在海外主要是锂矿勘探、开采和选矿业务。公司将持续关注相关行业的最新动态。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300039835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300267","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603098575","title":"异动快报：尔康制药（300267）1月13日10点30分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2603098575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603098575?lang=zh_cn&edition=full","pubTime":"2026-01-13 10:30","pubTimestamp":1768271441,"startTime":"0","endTime":"0","summary":"证券之星1月13日盘中消息，10点30分尔康制药触及涨停板。其所属行业化学制药目前上涨。领涨股为尔康制药。该股为AI医疗，合成生物，医药概念热股，当日AI医疗概念上涨4.79%，合成生物概念上涨2.94%，医药概念上涨1.95%。1月12日的资金流向数据方面，主力资金净流出229.34万元，占总成交额1.24%，游资资金净流出44.79万元，占总成交额0.24%，散户资金净流入274.14万元，占总成交额1.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300012017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0077","300267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591980623","title":"尔康制药（300267）披露2025年第二次临时股东会决议公告，12月16日股价下跌2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591980623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591980623?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:11","pubTimestamp":1765894315,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘，尔康制药报收于3.4元，较前一交易日下跌2.58%，最新总市值为70.13亿元。该股当日开盘3.49元，最高3.49元，最低3.4元，成交额达9137.42万元，换手率为1.87%。尔康制药近日发布公告称，公司于2025年12月16日召开2025年第二次临时股东会，出席会议的股东及代理人共计313名，代表股份1,011,948,647股，占公司有表决权股份总数的49.0617%。各项议案均获通过，表决程序符合相关法律法规及公司章程规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600040583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300267","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590344407","title":"尔康制药（300267）披露完成工商变更登记公告，12月09日股价下跌4.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590344407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590344407?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:11","pubTimestamp":1765289495,"startTime":"0","endTime":"0","summary":"截至2025年12月9日收盘，尔康制药报收于3.65元，较前一交易日下跌4.45%，最新总市值为75.29亿元。该股当日开盘3.8元，最高3.81元，最低3.65元，成交额达2.19亿元，换手率为4.17%。尔康制药近日发布公告称，公司已于近期完成工商变更登记手续，并取得长沙市市场监督管理局换发的《营业执照》。此次变更涉及公司经营范围及注册资本等内容。上述变更事项已于2025年11月14日经公司2025年第一次临时股东大会审议通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900040320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0028","300267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589789242","title":"尔康制药：有缓解流感症状药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2589789242","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589789242?lang=zh_cn&edition=full","pubTime":"2025-12-05 20:49","pubTimestamp":1764938973,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药(300267)12月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司生产的药品可以抗病毒和治疗流感吗？公司的锂矿和药品各占比多少？谢谢。尔康制药回复：尊敬的投资者，您好！目前公司有可以缓解流感相关疾病症状的药品，如：复方甘草片为止咳类药品；对乙酰氨基酚片为解热镇痛类药品；氨咖黄敏胶囊为抗感冒类药品。根据公司2025年半年度报告，公司新能源行业营业收入与医药行业营业收入的比重约为1:4。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500036879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300267","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589922298","title":"尔康制药：尼日利亚孙公司锂矿已投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2589922298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589922298?lang=zh_cn&edition=full","pubTime":"2025-12-05 20:49","pubTimestamp":1764938972,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药(300267)12月05日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘好，请问利亚锂矿什么时候可投产？矿的品位怎么样？谢谢！尔康制药回复：尊敬的投资者，您好！公司在尼日利亚的孙公司尔康矿业主要从事锂矿勘探、开采和加工业务，于2024年第四季度建成投产以来，以锂精矿产品生产为主，生产效率、产量持续提升。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500036878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0028","300267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586827225","title":"尔康制药（300267）披露召开2025年第二次临时股东会通知，11月27日股价下跌1.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586827225","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586827225?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:11","pubTimestamp":1764252680,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，尔康制药报收于3.97元，较前一交易日下跌1.73%，最新总市值为81.89亿元。该股当日开盘4.06元，最高4.11元，最低3.91元，成交额达2.97亿元，换手率为5.27%。近日，尔康制药发布公告称，公司将于2025年12月16日召开2025年第二次临时股东会，会议由董事会召集，采用现场与网络投票相结合的方式进行。中小股东的表决情况将单独计票，网络投票将通过深交所系统进行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300267","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584764697","title":"尔康制药（300267）披露选举第六届董事会成员，11月17日股价下跌0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584764697","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584764697?lang=zh_cn&edition=full","pubTime":"2025-11-17 17:31","pubTimestamp":1763371869,"startTime":"0","endTime":"0","summary":"截至2025年11月17日收盘，尔康制药报收于3.89元，较前一交易日下跌0.51%，最新总市值为80.24亿元。近日，尔康制药发布2025年第一次临时股东大会决议公告。出席会议股东及授权代表共261名，代表股份占公司总股份的48.7916%。本次会议召集、召开及表决程序符合法律法规及《公司章程》规定，决议合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700023405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","300267","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582705683","title":"尔康制药（300267）披露选举第六届董事会职工代表董事，11月12日股价上涨0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582705683","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582705683?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:43","pubTimestamp":1762958597,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，尔康制药报收于3.88元，较前一交易日上涨0.78%，最新总市值为80.03亿元。公司近日发布公告称，湖南尔康制药股份有限公司于2025年11月12日召开职工代表大会，选举赵寻女士为第六届董事会职工代表董事。赵寻女士现任公司董事、财务总监，符合相关法律法规规定的任职资格和条件。公司第六届董事会中由职工代表担任的董事及兼任高级管理人员的董事人数未超过董事总数的二分之一，符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267","BK0239","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581972756","title":"尔康制药：暂无直接针对减肥领域的专项产品及业务布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2581972756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581972756?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:51","pubTimestamp":1762347070,"startTime":"0","endTime":"0","summary":"证券之星消息，尔康制药(300267)11月04日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司在减肥领域有涉足吗？尔康制药回复：尊敬的投资者，您好！目前，公司生产的成品药主要为抗菌、止血、止咳、平喘类注射剂及治疗肾病、胃病、补益安神类中成药等，暂无直接针对减肥领域的专项产品及业务布局。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500038607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300267","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579011051","title":"尔康制药（300267）2025年三季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2579011051","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579011051?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:48","pubTimestamp":1761864539,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期尔康制药发布2025年三季报。根据财报显示，尔康制药营收净利润同比双双增长。截至本报告期末，公司营业总收入10.06亿元，同比上升17.81%，归母净利润3957.59万元，同比上升255.4%。按单季度数据看，第三季度营业总收入3.25亿元，同比上升39.32%，第三季度归母净利润194.12万元，同比上升106.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100009903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517963924","title":"尔康制药新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2517963924","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517963924?lang=zh_cn&edition=full","pubTime":"2025-03-06 05:26","pubTimestamp":1741210010,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日湖南尔康制药股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来湖南尔康制药股份有限公司新申请注册商标1件，截止目前公司共持有注册商标222件，另有20件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030600004515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300267","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776456456095,"stockEarnings":[{"period":"1week","weight":0.0025},{"period":"1month","weight":0.0203},{"period":"3month","weight":0.0152},{"period":"6month","weight":0.1754},{"period":"1year","weight":0.6962},{"period":"ytd","weight":0.1789}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":-0.0028},{"period":"3month","weight":-0.0123},{"period":"6month","weight":0.0551},{"period":"1year","weight":0.2351},{"period":"ytd","weight":0.0208}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南尔康制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"49105人(较上一季度增加14.88%)","perCapita":"28966股","listingDate":"2011-09-27","address":"湖南省长沙市浏阳市经济开发区康平路167号","registeredCapital":"206260万元","survey":" 湖南尔康制药股份有限公司的主营业务是辅料、原料药、成品药、新能源材料的生产和销售。公司的主要产品是药用辅料、成品药、原料药。","listedPrice":17.97},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"尔康制药(300267)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供尔康制药(300267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"尔康制药,300267,尔康制药股票,尔康制药股票老虎,尔康制药股票老虎国际,尔康制药行情,尔康制药股票行情,尔康制药股价,尔康制药股市,尔康制药股票价格,尔康制药股票交易,尔康制药股票购买,尔康制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"尔康制药(300267)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供尔康制药(300267)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}